Accuray Inc. has introduced the InTempo™ Adaptive Imaging System, which enhances the ability of the CyberKnife® Robotic Radiosurgery System to continually track and correct for motion of the prostate during treatment. The InTempo System helps the radiation delivery with the CyberKnife System in adapting to patient-specific prostate motion automatically. Along with the CyberKnife System’s correction for movement in real time, ensuring delivery of prescribed doses to the prostate. Also, it helps in keeping the adjoining sensitive features safe.

Covidien Ltd., a leading provider of advanced energy-based surgical systems has announced the global launch of its new Evident™ microwave ablation system. Designed to coagulate soft tissue during laparoscopic, percutaneous and open surgical procedures, evident system produces heat through the vibration of molecules of water. Microwave energy is then emitted from the feed point of the radiating part of the antenna. This results in the soft tissue’s coagulation. Evident™, that has received the CE Mark approval, is now the first microwave ablation system to be available worldwide.

Lutronic, Inc.’s. eCO2 system has received regulatory clearance from the U.S. Food and Drug Administration. Based on the Controlled Chaos Technology (CCT), this laser offers a safe treatment of deep ablative indications like resurfacing and coagulation of soft tissue, textural irregularities and pigmented lesions. Also, the system is easy to use and has reduced pain and discomfort to the patients. With numerous patents pending, the eCO2 has added features like a software that can select between a random or sequential beam pattern etc.

A research published in the official medical journal of the American Society of Plastic Surgeons (ASPS), Plastic and Reconstructive Surgery®, details a new back lift procedure which removes unsightly bumps and bulges while hiding the scars under the bra line. This procedure will facilitate those who wish to wear body hugging clothes. The procedure takes about an hour from start to finish and has minimal complications. It is a safe method to contour the upper and middle back, removing all the rolls and folds.

The U.S. Food and Drug Administration has approved BSD Medical Corporation’s microwave surgical device MicroThermx, which is designed for use by surgeons to ablate soft tissue. This is used as a treatment for coronary artery disease by restoring blood flow to the heart. It is a moveable device that includes a computer, microwave generator and disposable applicators. The company has made a point that after the sale of system, use of disposable parts would give the company a source of ongoing revenue.

CryoLife Inc.’s BioGlue Surgical Adhesive has received a CE Mark approval for its use in periosteal fixation that follows endoscopic browplasty (brow lift), a reconstructive procedure of cosmetic surgery. The product can now be marketed in the European Community (EU) by CryoLife’s partner BioForm Medical under the name “BioGlue Aesthetic(TM) Medical Adhesive. Commercial launch of BioGlue in the EU will follow after further clinical development is completed. However, the product will be available in Europe on a limited basis that will help in the evaluation and development program.

The U.S. Food and Drug Administration has granted PEAK Surgical, Inc 510(k) clearance to market its PEAK(R) Surgery System for use in general surgery. The medical device company has developed this new tissue dissection system based on a proprietary technology. It combines the PULSAR Generator, which supplies pulsed plasma radiofrequency energy, with the PEAK PlasmaBlade 4.0, a low-temperature surgical cutting and coagulation tool. This will make the cutting process more accurate and control bleeding. The new surgery system will be available in the market by next month.